PHARMACEUTICAL MANUFACTURING FORMULATIONS - AN OVERVIEW

These types of carryover should not cause the carryover of degradants or microbial contamination that could adversely alter the founded API impurity profile.All deviation, investigation, and OOS reports needs to be reviewed as Section of the batch document evaluation before the batch is unveiled.Written processes should be established assigning dut